| Literature DB >> 20150913 |
X Li1, Q Ma, J Wang, X Liu, Y Yang, H Zhao, Y Wang, Y Jin, J Zeng, J Li, L Song, X Li1, P Li, X Qian, C Cao.
Abstract
Galectin-3 (Gal3) has important roles in tumor transformation and metastasis. This study shows that c-Abl and Abl-related gene (Arg) associate with and phosphorylate Gal3. The SH (Src homology)3 domains of c-Abl/Arg bind to a P(80)GPPSGP motif of Gal3, and Tyr79 and Tyr118 are the major tyrosine phosphorylation sites. A consequence of this interaction and phosphorylation is the significant impairment of chaperone-mediated autophagy of Gal3. Cells expressing Gal3 and treated with the c-Abl/Arg inhibitor STI571, Gal3-depleted cells, and Gal3-depleted cells expressing Gal3 phosphorylation mutants all display an increased sensitivity to apoptosis-inducing agents. In addition, tumor cells expressing the phosphorylation mutants show impaired tumorigenicity. These results partially explain the antiapoptotic effect of Abl and Arg. As tumors frequently overexpress Gal3, a c-Abl/Arg-specific inhibitor may potentially be applied along with other antitumor drugs to target the lysosomal degradation of Gal3 in tumor therapy.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20150913 DOI: 10.1038/cdd.2010.8
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828